New product added – Rosuvastatin sprinkle capsules
/by Jan FlynnRosuvasatin sprinkle capsules can are designed to be opened and the extended release coated pellets may be sprinkled over soft food, taken whole or via a nasogastric tube.
New products added – Posaconazole & Cannabidiol
/by Jan FlynnWe have added two new products to the database today, Posaconazole & Cannabidiol. If there are product that you would like us to investigate and add to our database, please email us on info@changemed.co.uk
Database update Dasatinib
/by Jan FlynnInformation on Dasatinib has been added to the database.
Website Database Updated
/by Jan FlynnWe have been working very hard to update the database and add more useful information and additional formulations. we hope that you find this additional information useful. Let us know if there is more information that you would like to see on the website.
Zonisamide update
/by Jan FlynnA new oral liquid zonisamide has recently been launched in the UK and this information has been added to the product page.
New Medication Added
/by Jan FlynnRivaroxaban (Xarelto) has been added to the database
New medications added
/by Hattie Whiteside
Afatinib and Albendazole
New monographs available for:
Afatinib – licensed for administration via gastric tubes. The medication can also be dissolved in water to aid patients with swallowing difficulties. See the monograph for full information.
Albendazole- unlicensed medication available as an imported special on a named patient basis. Limited information available. See the monograph for full information.
New products launched.
/by Product AdminGlenmark Pharma have two new branded generic soluble products. Glensoludex is a soluble dexamethasone tablet, available in strengths of 2mg, 4mg and 8mg. Glensoludex is indicated for use in certain endocrine and non-endocrine disorders, in certain cases of cerebral oedema and for diagnostic testing of adrenocortical hyperfunction.
Alzhok is a soluble memantine tablet, available in strengths of 5mg, 10mg, 15mg, 20mg. Alzhok is indicated for the treatment of adult patients with moderate to severe Alzheimer’s disease.